Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester.
Viruses
; 14(2)2022 02 02.
Article
in En
| MEDLINE
| ID: mdl-35215900
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pregnancy Trimester, Third
/
Immunogenicity, Vaccine
/
COVID-19
/
BNT162 Vaccine
/
Ad26COVS1
/
Antibodies, Viral
Type of study:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Language:
En
Journal:
Viruses
Year:
2022
Document type:
Article
Affiliation country:
Romania
Country of publication:
Switzerland